Marqeta director Cummings plans $77.6K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Marqeta, Inc. director Martha Cummings reported an intended sale of 20,536 common shares, with an aggregate market value of $77,626.08 and an approximate sale date of June 12, 2026. The shares were acquired upon restricted stock unit vesting from June 12, 2025 through June 12, 2026. The reported date for Rule 10b5-1 plan adoption or instruction is September 11, 2025.
The past-three-months table lists three sales of 2,853 shares each: May 15, 2026, for gross proceeds of $10,980.91; April 15, 2026, for $11,751.22; and March 16, 2026, for $11,356.94. Each is labeled a Rule 10b5-1 sale.
Key Figures
Key Terms
Restricted Stock Units financial
Rule 10b5-1 regulatory
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What recent sales did Martha Cummings report for MQ?
AI-generated analysis. How Rhea-AI works. Not financial advice.